# reload+after+2024-01-20 07:47:16.614313
address1§2882 Sand Hill Road, Suite 106
address2§Menlo Park
city§Cambridge
state§MA
zip§94025
country§United States
phone§650 460 8308
website§https://www.summittxinc.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company's product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical stage for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. for research and develop Ivonescimab (AK112) and SMT112, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.
fullTimeEmployees§76
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Robert W. Duggan', 'age': 79, 'title': 'Co-CEO & Executive Chairman', 'yearBorn': 1944, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mahkam  Zanganeh D.D.S., M.B.A.', 'age': 53, 'title': 'Co-CEO, President & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 934849, 'exercisedValue': 0, 'unexercisedValue': 55794}, {'maxAge': 1, 'name': 'Mr. Ankur  Dhingra', 'age': 47, 'title': 'Chief Financial Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 668386, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Manmeet Singh Soni', 'age': 45, 'title': 'COO & Director', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Urte  Gayko Ph.D.', 'age': 52, 'title': 'Chief Regulatory, Quality & Pharmacovigilance Officer?', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Dame Kay Davies DBE, FRS CBE', 'age': 72, 'title': 'Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor', 'yearBorn': 1951, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Abby Guzman Murphy', 'title': 'Head of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Divya  Chari', 'age': 55, 'title': 'Head of Global Clinical Operations', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Dave  Gancarz', 'title': 'Chief Business & Strategy Officer?', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Will  Black', 'title': 'Head of Information Technology?', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§9
compensationRisk§7
shareHolderRightsRisk§5
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-1.114
priceToSalesTrailing12Months§Infinity
currency§USD
dateShortInterest§1702598400
forwardEps§-1.08
exchange§NGM
quoteType§EQUITY
shortName§Summit Therapeutics Inc.
longName§Summit Therapeutics Inc.
firstTradeDateEpochUtc§1425565800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d8568743-2bb7-3bc5-b04d-4193fee0ce0a
gmtOffSetMilliseconds§-18000000
recommendationMean§1.0
recommendationKey§strong_buy
quickRatio§1.756
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
